# Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies.

> **NCT01728389** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Maria Sklodowska-Curie National Research Institute of Oncology** · enrollment: 10 (estimated)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **PROCEDURE:** Intrabone transplantation

## Key facts

- **NCT ID:** NCT01728389
- **Lead sponsor:** Maria Sklodowska-Curie National Research Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2013-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728389, "Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01728389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*